Literature DB >> 24099976

Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.

Kenneth A Ellenbogen1, Bruce D Gunderson, Kurt D Stromberg, Charles D Swerdlow.   

Abstract

BACKGROUND: The Lead Integrity Alert (LIA) was developed for Medtronic implantable cardioverter defibrillators to reduce inappropriate shocks for rapid oversensing caused by conductor fractures and reported for Medtronic Fidelis conductor fractures. The goal of this study was to compare the performance of LIA with conventional impedance monitoring for identifying lead system events (LSEs) and lead failures (LFs) in lead families that differ from Fidelis. METHODS AND
RESULTS: We analyzed data from 12 793 LIA enabled implantable cardioverter-defibrillator and lead combinations including 6123 St. Jude Riata or Durata, 5114 Boston Scientific Endotak, and 1556 Fidelis combinations followed in the CareLink remote monitoring network for LSEs and LFs. Each alert was adjudicated based on implantable cardioverter-defibrillator stored electrograms/diagnostics and clinical data as an LSE or non-lead system event by 2 physicians after reviewing the electrograms and clinical data. During 13 562 patient-years of LIA follow-up, there were 179 adjudicated alerts, of which 84 were LSEs (including 65 LFs) and 95 were non-lead system events. LIA identified >66% more LSE and >67% more LF compared with conventional impedance monitoring and did not differ by lead family for LSE (P=0.573) or LF (P=0.332). Isolated spikes on electrogram were associated more often with LF in St. Jude leads (71%) compared with Endotak (9%; P<0.001) and Fidelis leads (11%; P<0.001). The non-lead system event detection rate was different among lead families (P<0.001) ranging from 1 in every 78.5 years (Endotak), 228.9 years (St. Jude leads), and 627.6 years (Fidelis).
CONCLUSIONS: LIA markedly increased the detection rate of LSE compared with conventional impedance monitoring.

Entities:  

Keywords:  defibrillators, implantable; lead failure; shock

Mesh:

Year:  2013        PMID: 24099976     DOI: 10.1161/CIRCEP.113.000744

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  9 in total

Review 1.  Sensing and detection in Medtronic implantable cardioverter defibrillators.

Authors:  Mark L Brown; Charles D Swerdlow
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09-08

Review 2.  Transvenous Implantable Cardioverter-Defibrillator (ICD) Lead Performance: A Meta-Analysis of Observational Studies.

Authors:  Rui Providência; Daniel B Kramer; Dominic Pimenta; Girish G Babu; Laura A Hatfield; Adam Ioannou; Jan Novak; Robert G Hauser; Pier D Lambiase
Journal:  J Am Heart Assoc       Date:  2015-10-30       Impact factor: 5.501

3.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Authors:  Bruce L Wilkoff; Laurent Fauchier; Martin K Stiles; Carlos A Morillo; Sana M Al-Khatib; Jesœs Almendral; Luis Aguinaga; Ronald D Berger; Alejandro Cuesta; James P Daubert; Sergio Dubner; Kenneth A Ellenbogen; N A Mark Estes; Guilherme Fenelon; Fermin C Garcia; Maurizio Gasparini; David E Haines; Jeff S Healey; Jodie L Hurtwitz; Roberto Keegan; Christof Kolb; Karl-Heinz Kuck; Germanas Marinskis; Martino Martinelli; Mark McGuire; Luis G Molina; Ken Okumura; Alessandro Proclemer; Andrea M Russo; Jagmeet P Singh; Charles D Swerdlow; Wee Siong Teo; William Uribe; Sami Viskin; Chun-Chieh Wang; Shu Zhang
Journal:  J Arrhythm       Date:  2016-02-01

4.  Myopotential oversensing notified by Lead Integrity Alert in a patient with implantable cardioverter defibrillator with a dedicated bipolar epicardial sensing lead.

Authors:  Kyoichiro Yazaki; Yoichi Ajiro; Shun Hasegawa; Masahiro Watanabe; Kei Tsukamoto; Keiko Mizobuchi; Takashi Saito; Fumiaki Mori; Kazunori Iwade
Journal:  Clin Case Rep       Date:  2016-10-11

5.  Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention.

Authors:  Aimé Bonny; Mohammed A Talle; Thibaut Vaugrenard; Jérôme Taieb; Marcus Ngantcha
Journal:  Indian Pacing Electrophysiol J       Date:  2016-10-24

6.  Failure of Lead Integrity Alert to detect implantable cardioverter-defibrillator lead-system failure in a pacemaker-dependent patient.

Authors:  Danesh K Kella; Bruce S Stambler
Journal:  HeartRhythm Case Rep       Date:  2020-08-31

7.  Inappropriate detection of an intraventricular conduction delay as a lead failure due to an increase in the sensing integrity counter in a patient with a cardiac resynchronization therapy-defibrillator.

Authors:  Kentaro Ozu; Hitoshi Minamiguchi; Shozo Konishi; Hiroya Mizuno; Yasushi Sakata
Journal:  HeartRhythm Case Rep       Date:  2020-10-24

8.  Ventricular arrhythmia management in patients with genetic cardiomyopathies.

Authors:  Zain I Sharif; Steven A Lubitz
Journal:  Heart Rhythm O2       Date:  2021-12-17

9.  A case report of lead dysfunction presenting as high ventricular premature complex burden.

Authors:  Saurabh Ajit Deshpande; Ameya Udyavar
Journal:  Indian Pacing Electrophysiol J       Date:  2021-10-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.